Taro Pharmaceutical Industries Ltd. has received approval from the Food and Drug Administration for Topicort Topical Spray 0.25%. The company said Friday that the Topicort (desoximetasone) spray, a corticosteroid, is indicated for the treatment of plaque psoriasis in patients age 18 and older.
Taro Pharmaceutical Industries Ltd. has received approval from the Food and Drug Administration for Topicort Topical Spray 0.25%.
The company said Friday that the Topicort (desoximetasone) spray, a corticosteroid, is indicated for the treatment of plaque psoriasis in patients age 18 and older.
In the United States, the corticosteroid spray market has estimated annual sales of $100 million, according to Taro.
Move to drive the launch of RedSail Pay, a comprehensive Merchant services solution.
The assortment of gut-friendly supplements delivers a range of easy and accessible nutrition solutions for daily digestive and immune system health support, as well as occasional symptom relief.
New campaign features Kelly Flagg, mom of top athlete Cooper Flagg.
Includes four planned new manufacturing facilities, with ground-breaking today in North Carolina on $2 billion+ facility.
Move to drive the launch of RedSail Pay, a comprehensive Merchant services solution.
The Super Savings Week runs online from March 24 to April 1, offering great deals across top categories.
The FDA has yet to comment on how it will proceed. Eli Lilly could pursue legal action against compounding pharmacies.
For the second consecutive year, McKesson collaborated with organizations such as Genentech, Kenvue, and the Leukemia & Lymphoma Society to educate more than 2,300 Navajo Nation members on cancer, diabetes, and nutrition.
